TARS
TARSUS PHARMACEUTICALS INC Earnings Dividend
$63.91
Earnings Summary
Revenue | $151.67Mn |
Net Profits | $-8.37Mn |
Net Profit Margins | -5.52% |
TARSUS PHARMACEUTICALS INC’s revenue jumped 128.39% since last year same period to $151.67Mn in the Q4 2025. On a quarterly growth basis, TARSUS PHARMACEUTICALS INC has generated 27.78% jump in its revenue since last 3-months.
TARSUS PHARMACEUTICALS INC’s net profit jumped 63.77% since last year same period to $-8.37Mn in the Q4 2025. On a quarterly growth basis, TARSUS PHARMACEUTICALS INC has generated 33.47% jump in its net profits since last 3-months.
TARSUS PHARMACEUTICALS INC’s net profit margin jumped 84.14% since last year same period to -5.52% in the Q4 2025. On a quarterly growth basis, TARSUS PHARMACEUTICALS INC has generated 47.93% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Current Year | -0.03 |
TARSUS PHARMACEUTICALS INC’s earning per share (EPS) estimates for the current quarter stand at -0.03 - a 68.3% jump from last quarter’s estimates.
TARSUS PHARMACEUTICALS INC’s earning per share (EPS) estimates for the current year stand at -0.03.
Key Ratios
Earning Per Share (EPS) | 0 |
TARSUS PHARMACEUTICALS INC’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the TARSUS PHARMACEUTICALS INC has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -0.03 | 0 | 100% |
